osteoporosis market expected to boom
TRANSCRIPT
22 MARKET NEWS
Osteoporosis market expected to boom
The hormone replacement therapy (HRT) market is set to dramatically expand, with 4-fold growth revenues of $US3.1 billion (at 1992 prices) achievable by 2002, according to a new study 'Pharmacast Osteoporosis' from Strategic Forecasting Services. Revenues for the HRT market were $680 million in 1992. Most of the growth is expected to occur in the next 5 years.
This anticipated explosion in the HRT market will be driven by increased screening, new product formulations/delivery systems, demographic changes and especially by increased awareness and desire for the benefits of HRT from both postmenopausal women and physicians.
The market for other 'osteoporotic drugs' (vitamin D, calcitonins and bone growth regulators) are expected to increase by almost a third by 2002, achieving revenues of $880 million. The major growth will be steered by bisphosphonates and calcium products.
800212905
25 Sep 1993 INPHARMA'" ISSN 0156-2703l9310925-00221$1.00c Adls International Ltd